Glow

Comment on this storyNote Add to your saved stories Save Federal health authorities are intensifying their scrutiny of the drug ketamine for treating mental health disorders, because the mind-altering compound is growing in popularity despite the lack of regulatory approval for such use. The Food and Drug Administration warned in October about the risks of…